Saturday 7 November 2026 Export PGEN’s income statement to Excel — free account

Precigen, Inc.

PGEN Healthcare Biotechnology

Precigen, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.7 million, up 146.7% from fiscal 2024.

Revenue: +2,437.6%
EPS: +109.4%
Free cash flow: +140.3%
Total debt: +1.47%

Quarter to September 2026, against a year earlier

Insider buying

4.43 0.21 +4.98%

Follow PGEN

Alert me

Market cap: $1.5B
P/E: 60.3×
Fwd P/E: 20.8×
Dividend yield: —
F-score: 3/9
Altman Z: −16.93
Beneish M: −7.67
Dividend safety: n/a

Overview

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
ROE Full definition →	38.84%	(9,907.46%)	(12,417.99%)	(1,446.02%)	+8 more TTM periods Free account
Piotroski F-Score Full definition →	6	4	4	3
ROA Full definition →	12.73%	(247.40%)	(286.76%)	(285.69%)
ROIC Full definition →	15.93%	(24.87%)	(102.06%)	(425.63%)
Return on Tangible Assets Full definition →	15.82%	(285.75%)	(408.82%)	(468.60%)
Average Days of Receivables Full definition →	224.71	306.78	308.51	164.41
Free Cash Flow per Share Full definition →	(0.21)	(0.32)	(0.33)	(0.29)
Free Cash Flow Full definition →	(74.32)	(115.22)	(116.96)	(89.83)
Capital Expenditures Full definition →	(1.10)	(1.06)	(1.63)	(1.99)
Other line items
Cash ROIC Full definition →	(33.16%)	(65.59%)	(68.80%)	(42.38%)
Accounts Receivable Turnover Full definition →	3.21	2.36	2.28	3.51
Accounts Payable Turnover Full definition →	2.02	1.73	2.21	0.62
Inventory Turnover Full definition →	1.04	0.78	0.84	0.98
Average Days of Payables Full definition →	191.23	242.15	150.43	907.01
Days of Inventory on Hand Full definition →	621.03	924.26	855.56	725.08
Tax Rate Full definition →	(0.01)	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	16.91%	37.67%	115.50%	426.82%
Selling, General and Administrative Expense of Revenue Full definition →	53.08%	99.09%	249.46%	724.16%
Share Based Compensation of Revenue Full definition →	8.32%	15.94%	37.10%	117.65%
Interest Coverage Full definition →	2.85	(4.06)	(13.86)	(28.58)
Operating CF/Net income Full definition →	(3.00)	0.34	0.30	0.20
Depreciation/Fixed assets Full definition →	0.33	0.28	0.48	0.38
Capex/Depreciation Full definition →	(0.25)	(0.29)	(0.25)	(0.38)
Revenue per Share Full definition →	0.44	0.24	0.09	0.03
Operating CF per Share Full definition →	(0.20)	(0.32)	(0.33)	(0.28)
Capex per Share Full definition →	0.00	0.00	0.00	(0.01)
Capex to Sales Full definition →	0.01	0.01	0.05	0.21

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly